Metallothioneins are multipurpose neuroprotectants during brain pathology (Q36460899)

14 August 2017

1 reference

title

Metallothioneins are multipurpose neuroprotectants during brain pathology (English)

1 reference

14 August 2017

1

Milena Penkowa

0 references

language of work or name

English

0 references

publication date

1 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

273

1 reference

14 August 2017

9

1 reference

14 August 2017

1857-1870

1 reference

Regulation, Linkage, and Sequence of Mouse Metallothionein I and II Genes

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05207.X

Signaling events for metallothionein induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05207.X

The role of metallothionein II in neuronal differentiation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05207.X

Role of metallothioneins in peripheral nerve function and regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05207.X

Protective role of metallothioneins in the injured mammalian brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05207.X

trans repression of the human metallothionein IIA gene promoter by PZ120, a novel 120-kilodalton zinc finger protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05207.X

Evidence for differences in the post-transcriptional regulation of rat metallothionein isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05207.X

Metallothionein biodegradation in rat hepatoma cells: a compartmental analysis aided 35S-radiotracer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05207.X

Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05207.X

Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes 2005;54:3089-3094

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.2337/DIABETES.54.11.3089

Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/JNR.10615

M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1006/EXNR.2002.7968

Identifiers

DOI

10.1111/J.1742-4658.2006.05207.X

1 reference

14 August 2017

1 reference

PubMed ID

16640552